Overview
- 132 inspections across 111 sites are on record.
- 313 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-12-11.
At a glance
Inspections
132
Sites
111
Observations
313
Career since
Mar 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Medline Industries, LP | 11 Dec 2025 | Human Drugs | |
| Outlook Group, LLC | 15 May 2025 | Human Drugs | View 483 → |
| Ailex Pharmaceuticals LLC | 16 Apr 2025 | Human Drugs | View 483 → |
| Cambrex Charles City, Inc | 7 Mar 2025 | Human Drugs | On file |
| Acceleration Laboratory Services Inc. | 11 Jul 2024 | Human Drugs | View 483 → |
Sites inspected
Medline Industries, LPWaukegan, United States1 insp.
Outlook Group, LLCNeenah, United States1 insp.
Ailex Pharmaceuticals LLCLenexa, United States1 insp.
Cambrex Charles City, IncCharles City, United States1 insp.
Acceleration Laboratory Services Inc.Lees Summit, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Shirley J Berryman7 shared
Ashley A Mutawakkil4 shared
Zachary A Bogorad4 shared
Eric M Padgett4 shared
Tara L Breckenridge4 shared
Diana K Krepel3 shared
Jeffery A Hangartner3 shared
Matthew R Sleeter3 shared
James K Rice2 shared
Laura S Huffman2 shared
Full investigator report
Get the verbatim findings behind Michele L Obert's 313 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site